Revenue increased 13.4%
Revenue changed +13.4% from the comparable as-filed period.
$361.7M→$410.3M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →PATH financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin moved 185 bp lower
Gross margin changed -185 basis points from the comparable as-filed period.
82.20%→80.36%2 prior comparisons
Working capital / assets moved 1135 bp lower
Working capital / assets changed -1135 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
49.85%→38.50%4 prior comparisons
Research & development decreased 15.2%
Research & development changed -15.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$98.3M→$83.4M2 prior comparisons
R&D / revenue moved 686 bp lower
R&D / revenue changed -686 basis points from the comparable as-filed period.
27.19%→20.33%2 prior comparisons
Working capital decreased 13.4%
Working capital changed -13.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.3B→$1.1B4 prior comparisons
Free-cash-flow margin moved 435 bp lower
Free-cash-flow margin changed -435 basis points from the comparable as-filed period.
11.50%→7.14%2 prior comparisons
Operating cash-flow margin moved 401 bp lower
Operating cash-flow margin changed -401 basis points from the comparable as-filed period.
11.50%→7.48%2 prior comparisons
Current liabilities increased 9.3%
Current liabilities changed +9.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$738.4M→$807.3M4 prior comparisons
Gross profit increased 10.9%
Gross profit changed +10.9% from the comparable as-filed period.
$297.3M→$329.7M2 prior comparisons
Current assets decreased 5.1%
Current assets changed -5.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$2.0B→$1.9B4 prior comparisons
Cash & equivalents decreased 3.4%
Cash & equivalents changed -3.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$628.6M→$607.4M4 prior comparisons
Capex / revenue moved 34 bp higher
Capex / revenue changed +34 basis points from the comparable as-filed period.
0.00%→0.34%2 prior comparisons
Current ratio decreased 13.2%
Current ratio changed -13.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
2.75→2.394 prior comparisons
Receivables / revenue moved 27 bp higher
Receivables / revenue changed +27 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
74.59%→74.86%2 prior comparisons
Capital expenditure changed across a zero base
Capital expenditure changed +0.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
$0→$1.4M3 prior comparisons
Net income changed across a sign change
Net income changed +199.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$22.6M→$22.5M2 prior comparisons
Operating cash flow increased 10.9%
Operating cash flow changed +10.9% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes.
$119.0M→$131.9M6 prior comparisons
Gross profit increased 16.6%
Gross profit changed +16.6% from the comparable as-filed period.
$292.8M→$341.5M3 prior comparisons
Cash & equivalents decreased 9.8%
Cash & equivalents changed -9.8% from the comparable as-filed period.
$700.6M→$632.2M2 prior comparisons
Gross margin moved 48 bp lower
Gross margin changed -48 basis points from the comparable as-filed period.
82.09%→81.61%3 prior comparisons
Research & development decreased 2.0%
Research & development changed -2.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$94.8M→$92.9M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.